Malignant neoplasm of left main bronchus
ICD-10 C34.02 is a billable code used to indicate a diagnosis of malignant neoplasm of left main bronchus.
C34.02 refers to a malignant neoplasm located in the left main bronchus, which is a critical airway structure that branches from the trachea into the left lung. This type of lung cancer is often associated with significant morbidity and mortality, primarily due to its aggressive nature and late presentation. Risk factors include a history of smoking, exposure to secondhand smoke, occupational hazards, and environmental pollutants. The staging of lung cancer, particularly for bronchial tumors, follows the TNM classification system, which assesses tumor size (T), lymph node involvement (N), and distant metastasis (M). Molecular markers such as EGFR mutations, ALK rearrangements, and PD-L1 expression are increasingly important for targeted therapies and immunotherapy options. Treatment algorithms typically involve a multidisciplinary approach, including surgery, chemotherapy, radiation therapy, and targeted therapies, depending on the stage and specific characteristics of the tumor. Early detection and intervention are crucial for improving outcomes in patients diagnosed with this condition.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with cough, hemoptysis, or unexplained weight loss.
Ensure all relevant molecular testing results are included in the documentation.
Pulmonary function tests, imaging results, and smoking history must be documented.
Patients with chronic cough and a history of smoking presenting for evaluation.
Document any comorbid respiratory conditions that may affect treatment.
Used for diagnosis and staging of lung cancer.
Document indications for bronchoscopy and findings.
Pulmonology specialists should ensure thorough documentation of the procedure.
The primary risk factor for malignant neoplasm of the left main bronchus is a history of smoking, along with exposure to environmental toxins and genetic predispositions.